BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Niu ZS, Niu XJ, Wang WH. Genetic alterations in hepatocellular carcinoma: An update. World J Gastroenterol 2016; 22(41): 9069-9095 [PMID: 27895396 DOI: 10.3748/wjg.v22.i41.9069]
URL: https://www.wjgnet.com/1948-5182/full/v22/i41/9069.htm
Number Citing Articles
1
Qicong Mai, Dafeng Sheng, Chengcong Chen, Qing Gou, Meng Chen, Xiaoting Huang, Heng Yin, Xiaoming Chen, Zide Chen. Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC)Aging 2020; 12(24): 25395 doi: 10.18632/aging.104142
2
Saad Saffo, Tamar H. Taddei. Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment StrategiesDigestive Diseases and Sciences 2019; 64(4): 1016 doi: 10.1007/s10620-019-05582-x
3
Ting Lei, Xiaodong Zhu, Kai Zhu, Fuxin Jia, Siqiao Li. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathwayCancer Biology & Therapy 2019; 20(7): 1007 doi: 10.1080/15384047.2019.1595276
4
Germana Castelli, Elvira Pelosi, Ugo Testa. Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem CellsCancers 2017; 9(9): 127 doi: 10.3390/cancers9090127
5
Mazen Hassanain, Yang Liu, Weam Hussain, Albandri Binowayn, Duna Barakeh, Ebtehal Alsolme, Faisal AlSaif, Ghaida Almasaad, Mohammed AlSwayyed, Maram Alaqel, Rana Aljunidel, Sherin Abdelrahman, Charlotte A. E. Hauser, Saleh Alqahtani, Robert Hoehndorf, Malak Abedalthagafi. Genomic landscape in Saudi patients with hepatocellular carcinoma using whole-genome sequencing: a pilot studyFrontiers in Gastroenterology 2023; 2 doi: 10.3389/fgstr.2023.1205415
6
Ji‐Chang Fan, Fei Zeng, Yi‐Guan Le, Lin Xin. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR‐24‐3pJournal of Cellular Biochemistry 2018; 119(8): 6391 doi: 10.1002/jcb.26479
7
L.S.S. Srivani Nagam, Ramakrishna Vadde, Rajeswari Jinka. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma2022; : 125 doi: 10.1016/B978-0-323-98806-3.00013-1
8
Luis Cano, Stéphane Bertani, Marie-Laure Island, Juan Pablo Cerapio, Eloy Ruiz, Pascal Pineau, Valérie Monbet, Karim Boudjema, Luis Taxa, Sandro Casavilca-Zambrano, Martine Ropert, Bruno Turlin, Olivier Loréal. Metallomic profile in non-cirrhotic hepatocellular carcinoma supports a phenomenon of metal metabolism adaptation in tumor cellsScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93369-4
9
María Gárate-Rascón, Miriam Recalde, Carla Rojo, Maite G. Fernández-Barrena, Matías A. Ávila, María Arechederra, Carmen Berasain. SLU7: A New Hub of Gene Expression Regulation—From Epigenetics to Protein Stability in Health and DiseaseInternational Journal of Molecular Sciences 2022; 23(21): 13411 doi: 10.3390/ijms232113411
10
Ayoob D Abdullah, Hayder J. Taher, Hayder S. Alareer, Ahmed M. Easa, Hussein A. Dakhil, Raad A. Bustan. The Different MRI Features of Hepatocellular Adenoma and Hepatocellular CarcinomaJournal of Pharmacy and Bioallied Sciences 2023; 15(Suppl 2): S1046 doi: 10.4103/jpbs.jpbs_230_23
11
Md Abedul Haque. Current Cancer Biomarkers2023; : 195 doi: 10.2174/9789815079364123010013
12
Bárbara Ferreira, Adrián Heredia, Jacinta Serpa. An integrative view on glucagon function and putative role in the progression of pancreatic neuroendocrine tumours (pNETs) and hepatocellular carcinomas (HCC)Molecular and Cellular Endocrinology 2023; 578: 112063 doi: 10.1016/j.mce.2023.112063
13
Max J. Carlsson, Anastasia S. Vollmer, Philipp Demuth, Daniel Heylmann, Diana Reich, Caroline Quarz, Birgit Rasenberger, Teodora Nikolova, Thomas G. Hofmann, Markus Christmann, Julia A. Fuhlbrueck, Simone Stegmüller, Elke Richling, Alexander T. Cartus, Jörg Fahrer. p53 triggers mitochondrial apoptosis following DNA damage-dependent replication stress by the hepatotoxin methyleugenolCell Death & Disease 2022; 13(11) doi: 10.1038/s41419-022-05446-9
14
Liang Zhang, Yi Huang, Yi Zhu, Zhen Yu, Mengmeng Shao, Yunbo Luo. Identification and Characterization of Cadmium-Related Genes in Liver CarcinomaBiological Trace Element Research 2018; 182(2): 238 doi: 10.1007/s12011-017-1106-z
15
Xia Chen, Ling Liao, Yuwei Li, Hengliu Huang, Qing Huang, Shaoli Deng. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular CarcinomaBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/7653506
16
Karthikeyan Murugesan, Radwa Sharaf, Meagan Montesion, Jay A. Moore, James Pao, Dean C. Pavlick, Garrett M. Frampton, Vivek A. Upadhyay, Brian M. Alexander, Vincent A. Miller, Milind M. Javle, Tanios S. Bekaii Saab, Lee A. Albacker, Jeffrey S. Ross, Siraj M. Ali. Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or CholangiocarcinomaJCO Precision Oncology 2021; (5): 1285 doi: 10.1200/PO.20.00397
17
Aaron Koenig, Juan Barajas, María Guerrero, Kalpana Ghoshal. A Comprehensive Analysis of Argonaute-CLIP Data Identifies Novel, Conserved and Species-Specific Targets of miR-21 in Human Liver and Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2018; 19(3): 851 doi: 10.3390/ijms19030851
18
Xuejing Zhang, Hongling Li, Mingfeng Mao, Xiangyang Wang, Jingjing Zheng, Shunshi Yang. Mitotically‑associated long non‑coding RNA promotes cancer cell proliferation in hepatocellular carcinoma by downregulating miR‑122aOncology Letters 2019;  doi: 10.3892/ol.2019.10947
19
Haoming Lin, Rui Zhang, Wenrui Wu, Liming Lei. Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinomaCancer Genetics 2020; 245: 27 doi: 10.1016/j.cancergen.2020.04.076
20
Nehmé Saksouk, Shefqet Hajdari, Yannick Perez, Marine Pratlong, Célia Barrachina, Céline Graber, Damien Grégoire, Aliki Zavoriti, Amélie Sarrazin, Nelly Pirot, Jean-Yohan Noël, Lakhdar Khellaf, Eric Fabbrizio, Eric Julien, Florence M. Cammas. The mouse HP1 proteins are essential for preventing liver tumorigenesisOncogene 2020; 39(13): 2676 doi: 10.1038/s41388-020-1177-8
21
Shimaa Abdelsattar, Sally A. Fahim, Hala F. M. Kamel, Hiba Al-Amodi, Zeinab A. Kasemy, Fatma O. Khalil, Mahmoud S. Abdallah, Hanan M. Bedair, Abdel-Naser Abdel-Atty Gadallah, Aliaa Sabry, Mohamed A. Sakr, Mahmoud Selim, Eman M. Abd El Gayed. The Potential Role of Circulating Long Miscellaneous RNAs in the Diagnosis and Prognosis of Hepatitis C Related Hepatocellular CarcinomaNon-Coding RNA 2023; 9(5): 62 doi: 10.3390/ncrna9050062
22
Seung-Hun Kim, Wen-Hsing Wang, Jing-Ping Wang, Chang-Heng Hsieh, Kang Fang. Teroxirone suppresses growth and motility of human hepatocellular carcinoma cellsBiomedicine & Pharmacotherapy 2018; 99: 997 doi: 10.1016/j.biopha.2018.01.157
23
Nirmala Subramaniam, Pugazhendhi Kannan, Ashokkumar K, Devaki Thiruvengadam. Hepatoprotective effect of boldine against diethylnitrosamine‐induced hepatocarcinogenesis in wistar ratsJournal of Biochemical and Molecular Toxicology 2019; 33(12) doi: 10.1002/jbt.22404
24
Zhenggang Wu, Xi Long, Shui Ying Tsang, Taobo Hu, Jian-Feng Yang, Wai Kin Mat, Hongyang Wang, Hong Xue. Genomic subtyping of liver cancers with prognostic applicationBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6546-8
25
Alistair Rice, Armando del Rio Hernandez. The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNAFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00952
26
Shuixian Du, Songling Liao, Shousheng Liu, Yongning Xin. TM6SF2 E167K Variant Overexpression Promotes Expression of Inflammatory Cytokines in the HCC Cell Line HEPA 1-6Journal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2018.00055
27
Sayed Sartaj Sohrab, Riya Raj, Amka Nagar, Susan Hawthorne, Ana Cláudia Paiva-Santos, Mohammad Amjad Kamal, Mai M. El-Daly, Esam I. Azhar, Ankur Sharma. Chronic Inflammation’s Transformation to Cancer: A Nanotherapeutic ParadigmMolecules 2023; 28(11): 4413 doi: 10.3390/molecules28114413
28
Yi Quan, Jun Yang, Tao Qin, Yufang Hu. Associations between twelve common gene polymorphisms and susceptibility to hepatocellular carcinoma: evidence from a meta-analysisWorld Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1748-8
29
Michael Fasullo. DNA Repair- An Update2019;  doi: 10.5772/intechopen.81763
30
Daniele Fanale, Lidia Rita Corsini, Raimondo Scalia, Chiara Brando, Alessandra Cucinella, Giorgio Madonia, Alessandra Dimino, Clarissa Filorizzo, Nadia Barraco, Marco Bono, Alessia Fiorino, Luigi Magrin, Roberta Sciacchitano, Alessandro Perez, Tancredi Didier Bazan Russo, Gianni Pantuso, Antonio Russo, Viviana Bazan. Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?Critical Reviews in Oncology/Hematology 2022; 170: 103597 doi: 10.1016/j.critrevonc.2022.103597
31
Srinivas Reddy Pallerla, Nghiem Xuan Hoan, Sivaramakrishna Rachakonda, Christian G. Meyer, Hoang Van Tong, Nguyen Linh Toan, Le Thi Kieu Linh, Dao Phuong Giang, Peter G. Kremsner, Mai Hong Bang, Le Huu Song, Thirumalaisamy P. Velavan. Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinomaBMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01386-7
32
Celia Sequera, Sara Manzano, Carmen Guerrero, Almudena Porras. How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinomaHepatic Oncology 2018; 5(1): HEP05 doi: 10.2217/hep-2017-0026
33
Flavio Milana, Michela Anna Polidoro, Simone Famularo, Ana Lleo, Renzo Boldorini, Matteo Donadon, Guido Torzilli. Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current EvidenceCancers 2023; 15(2): 508 doi: 10.3390/cancers15020508
34
Bin Xi, Fang-Zhou Luo, Bin He, Fang Wang, Ze-Kuan Li, Ming-Chun Lai, Shu-Sen Zheng. High nuclear ABCG1 expression is a poor predictor for hepatocellular carcinoma patient survivalHepatobiliary & Pancreatic Diseases International 2022; 21(4): 370 doi: 10.1016/j.hbpd.2022.06.009
35
Jinpo Wang, Rongfeng Huang, Yuehong Huang, Yunxin Chen, Fenglin Chen. Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based AnalysisAdvances in Therapy 2021; 38(6): 3342 doi: 10.1007/s12325-021-01762-2
36
AA Mohamed, D Omran, S El-Feky, H Darwish, AEL Kassas, A Farouk, O Ezzat, SM Abdo, FE Zahran, A El-Demery, MM Omran. Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic indexBritish Journal of Biomedical Science 2021; 78(1): 18 doi: 10.1080/09674845.2020.1778842
37
Yajie Wang, Hua Sun, Zhiyan Xiao, Dan Zhang, Xiuqi Bao, Ning Wei. XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10577-7
38
Wen-Yong Wu, Si-Qi Tao, Xiao-Nan Wang, Peter E Lobie, Zheng-Sheng Wu. XIAP 3′-untranslated region serves as a competitor for HMGA2 by arresting endogenous let-7a-5p in human hepatocellular carcinomaTumor Biology 2017; 39(7): 101042831771957 doi: 10.1177/1010428317719578
39
Enakshi Sivasudhan, Neil Blake, Zhi-Liang Lu, Jia Meng, Rong Rong. Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular CarcinomaFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.642443
40
Guangyi Chen, Zhi-Ping Liu. Inferring causal gene regulatory network via GreyNet: From dynamic grey association to causationFrontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.954610
41
Pattapon Kunadirek, Natthaya Chuaypen, Piroon Jenjaroenpun, Thidathip Wongsurawat, Nutcha Pinjaroen, Pongserath Sirichindakul, Intawat Nookaew, Pisit Tangkijvanich. Cell-Free DNA Analysis by Whole-Exome Sequencing for Hepatocellular Carcinoma: A Pilot Study in ThailandCancers 2021; 13(9): 2229 doi: 10.3390/cancers13092229
42
Lifeng He, Xiaoxiao Fan, Yirun Li, Mingming Chen, Bin Cui, Guoqiao Chen, Yili Dai, Daizhan Zhou, Xiaotong Hu, Hui Lin. Overexpression of zinc finger protein 384 (ZNF 384), a poor prognostic predictor, promotes cell growth by upregulating the expression of Cyclin D1 in Hepatocellular carcinomaCell Death & Disease 2019; 10(6) doi: 10.1038/s41419-019-1681-3
43
Yongfu Xiong, Gang Yang, Kang Wang, Muhammad Riaz, Jian Xu, Zhenbing Lv, He Zhou, Qiang Li, Weinan Li, Ji Sun, Tang Tao, Jingdong Li. Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic SignificanceFrontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00879
44
Haojun Xiong, Yan Zhang, Shan Chen, Zhenhong Ni, Jintao He, Xinzhe Li, Bo Li, Kai Zhao, Fan Yang, Yijun Zeng, Bingbo Chen, Fengtian He. Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cellsOncotarget 2017; 8(38): 64083 doi: 10.18632/oncotarget.19321
45
Hyun-Soo Kim, Joon-Sup Yoon, Yoon Jeon, Eun-Ji Park, Jin-Kwan Lee, Si Chen, Ho Lee, Jee Young Park, Heounjeong Go, Chang-Woo Lee. Ssu72-HNF4α signaling axis classify the transition from steatohepatitis to hepatocellular carcinomaCell Death & Differentiation 2022; 29(3): 600 doi: 10.1038/s41418-021-00877-x
46
Malik Siddique Mahmood, Maryam Afzal, Hina Batool, Amara Saif, Tahreem Aqdas, Naeem Mahmood Ashraf, Mahjabeen Saleem. Screening of Pathogenic Missense Single Nucleotide Variants From LHPP Gene Associated With the Hepatocellular Carcinoma: An In silico ApproachBioinformatics and Biology Insights 2022; 16: 117793222211155 doi: 10.1177/11779322221115547
47
Zhenyu Zhang, Jinfeng Zhu, Yansong Huang, Weibing Li, Hongqiu Cheng. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathwayDiagnostic Pathology 2018; 13(1) doi: 10.1186/s13000-018-0763-3
48
Konstantinos Arvanitakis, Ioannis Mitroulis, Georgios Germanidis. Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and TherapyCancers 2021; 13(12): 2899 doi: 10.3390/cancers13122899
49
Yaqian Niu, Fang Liu, Xiuyue Wang, Yuling Chang, Yanmei Song, Huiyuan Chu, Shisan Bao, Che Chen. miR-183-5p Promotes HCC Migration/Invasion via Increasing Aerobic GlycolysisOncoTargets and Therapy 2021; : 3649 doi: 10.2147/OTT.S304117
50
Korosh Morshedi, Sarina Borran, Mohammad Saeid Ebrahimi, Mohammad Jaber Masoud khooy, Zeynab Sadat Seyedi, Atefeh Amiri, Mohammad Abbasi‐Kolli, Maryam Fallah, Haroon Khan, Amirhossein Sahebkar, Hamed Mirzaei. Therapeutic effect of curcumin in gastrointestinal cancers: A comprehensive reviewPhytotherapy Research 2021; 35(9): 4834 doi: 10.1002/ptr.7119
51
Aroosha Raja, Farhan Haq. Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applicationsJournal of Cancer Research and Clinical Oncology 2022; 148(1): 15 doi: 10.1007/s00432-021-03826-w
52
Guiming Hu, Fei Gao, Guanzhe Wang, Yan Fang, Yuanyuan Guo, Jun Zhou, Yuhan Gu, Cunzhen Zhang, Na Gao, Qiang Wen, Hailing Qiao. Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarkerJournal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-03038-3
53
Nazanin Hosseinkhan, Zahra Narimani, Nastaran Masoudi-Khoram, Mohammad E. Khamseh. The higher body mass index is associated with a lower somatic mutation dependency in hepatocellular carcinomaInformatics in Medicine Unlocked 2023; 37: 101187 doi: 10.1016/j.imu.2023.101187
54
Fanyun Kong, Delong Kong, Xiaoying Yang, Dongchen Yuan, Ning Zhang, Xuan Hua, Hongjuan You, Kuiyang Zheng, Renxian Tang. Integrative analysis of highly mutated genes in hepatitis B virus‐related hepatic carcinomaCancer Medicine 2020; 9(7): 2462 doi: 10.1002/cam4.2903
55
Alexandru Blidisel, Iasmina Marcovici, Dorina Coricovac, Florin Hut, Cristina Adriana Dehelean, Octavian Marius Cretu. Experimental Models of Hepatocellular Carcinoma—A Preclinical PerspectiveCancers 2021; 13(15): 3651 doi: 10.3390/cancers13153651
56
Dan Chen, Xiaoting Li, Hui Li, Kai Wang, Xianghua Tian, Jimei Wang. Identification of Immune-Related Prognostic mRNA and lncRNA in Patients with Hepatocellular CarcinomaJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5313149
57
Eman H. Yousef, Mohamed E El-Mesery, Maha R Habeeb, Laila A Eissa. Polo-like kinase 1 as a promising diagnostic biomarker and potential therapeutic target for hepatocellular carcinomaTumor Biology 2020; 42(4): 101042832091447 doi: 10.1177/1010428320914475
58
Tengfei Si, Zhenlin Huang, Yuanhang Jiang, Abigail Walker-Jacobs, Shaqira Gill, Robert Hegarty, Mohammad Hamza, Shirin Elizabeth Khorsandi, Wayel Jassem, Nigel Heaton, Yun Ma. Expression Levels of Three Key Genes CCNB1, CDC20, and CENPF in HCC Are Associated With Antitumor ImmunityFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.738841
59
Taiji Yamazoe, Taizo Mori, Sachiyo Yoshio, Tatsuya Kanto. Hepatocyte ploidy and pathological mutations in hepatocellular carcinoma: impact on oncogenesis and therapeuticsGlobal Health & Medicine 2020; 2(5): 273 doi: 10.35772/ghm.2020.01089
60
Ming-Chin Yu, Chao-Wei Lee, Yun-Shien Lee, Jang-Hau Lian, Chia-Lung Tsai, Yi-Ping Liu, Chun-Hsing Wu, Chi-Neu Tsai. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration dataWorld Journal of Gastroenterology 2017; 23(44): 7818-7829 doi: 10.3748/wjg.v23.i44.7818
61
Xing Liu, Aileen Baecker, Ming Wu, Jin‐Yi Zhou, Jie Yang, Ren‐Qiang Han, Pei‐Hua Wang, Zi‐Yi Jin, Ai‐Min Liu, Xiaoping Gu, Xiao‐Feng Zhang, Xu‐Shan Wang, Ming Su, Xu Hu, Zheng Sun, Gang Li, Alan Fu, Su Yon Jung, Lina Mu, Na He, Liming Li, Jin‐Kou Zhao, Zuo‐Feng Zhang. Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese populationLiver International 2019; 39(8): 1490 doi: 10.1111/liv.14182
62
Yanmeng Li, Anjian Xu, Siyu Jia, Jian Huang. Recent advances in the molecular mechanism of sex disparity in hepatocellular carcinoma (Review)Oncology Letters 2019;  doi: 10.3892/ol.2019.10127
63
Lorenza Rimassa, Maria Reig, Giovanni Abbadessa, Markus Peck-Radosavljevic, William Harris, Vittorina Zagonel, Davide Pastorelli, Elena Rota Caremoli, Camillo Porta, Nevena Damjanov, Hitendra Patel, Bruno Daniele, Maria Lamar, Brian Schwartz, Terri Goldberg, Armando Santoro, Jordi Bruix. Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinomaWorld Journal of Gastroenterology 2017; 23(13): 2448-2452 doi: 10.3748/wjg.v23.i13.2448
64
Xiaozhong Huang, Fan Lee, Yao Teng, Corey Bryen Lingam, Zijian Chen, Min Sun, Ziwei Song, Gowri M. Balachander, Hwa Liang Leo, Qiongyu Guo, Imran Shah, Hanry Yu. Sequential drug delivery for liver diseasesAdvanced Drug Delivery Reviews 2019; : 72 doi: 10.1016/j.addr.2019.11.001
65
Nadia O. M. Mangoud, Sahar A. Ali, Mohamed El Kassas, Sameh H. Soror. Chitinase 3‐like‐1, Tolloid‐like protein 1, and intergenic gene polymorphisms are predictors for hepatocellular carcinoma development after hepatitis C virus eradication by direct‐acting antiviralsIUBMB Life 2021; 73(2): 474 doi: 10.1002/iub.2444
66
Salvatore Gruttadauria, Floriana Barbera, Pier Giulio Conaldi, Duilio Pagano, Rosa Liotta, Enrico Gringeri, Roberto Miraglia, Gaetano Burgio, Marco Barbara, Giada Pietrosi, Calogero Cammà, Fabrizio Di Francesco. Clinical and Molecular-Based Approach in the Evaluation of Hepatocellular Carcinoma Recurrence after Radical Liver ResectionCancers 2021; 13(3): 518 doi: 10.3390/cancers13030518
67
Robert Eferl, Michael Trauner. Chromosomal instability in HCC: a key function for checkpoint kinase 2Gut 2018; 67(2): 204 doi: 10.1136/gutjnl-2017-314101
68
Ramesh C. Kovi, Sachin Bhusari, Deepak Mav, Ruchir R. Shah, Thai Vu Ton, Mark J. Hoenerhoff, Robert C. Sills, Arun R. Pandiri. Genome-wide promoter DNA methylation profiling of hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N miceArchives of Toxicology 2019; 93(8): 2219 doi: 10.1007/s00204-019-02505-7
69
Gui Wang, Yamei Qiao, Yunyan Zhao, Yuanyuan Song, Mengyang Li, Min Jin, Dong Yang, Jing Yin, Junwen Li, Weili Liu. Beauvericin exerts an anti-tumor effect on hepatocellular carcinoma by inducing PI3K/AKT-mediated apoptosisArchives of Biochemistry and Biophysics 2023; 745: 109720 doi: 10.1016/j.abb.2023.109720
70
Clara T. Nicolas, Caitlin J. VanLith, Raymond D. Hickey, Zeji Du, Lori G. Hillin, Rebekah M. Guthman, William J. Cao, Benjamin Haugo, Annika Lillegard, Diya Roy, Aditya Bhagwate, Daniel O’Brien, Jean-Pierre Kocher, Robert A. Kaiser, Stephen J. Russell, Joseph B. Lillegard. In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesionsNature Communications 2022; 13(1) doi: 10.1038/s41467-022-32576-7
71
Gustavo dos Santos Fernandes, Daniel Campos, Andre Ballalai, Rodrigo Palhares, Mario R. A. da Silva, Daniel M. F. Palhares, Ben-Hur F. Neto, Fabio M. do R. Barros, Roberto de A. Gil, Aline Chagas, Flair José Carrilho. Epidemiological and Clinical Patterns of Newly Diagnosed Hepatocellular Carcinoma in Brazil: the Need for Liver Disease Screening Programs Based on Real-World DataJournal of Gastrointestinal Cancer 2021; 52(3): 952 doi: 10.1007/s12029-020-00508-7
72
Hao Cheng, Yiming Pan, Yongzhong Yao, Zhanghua Zhu, Jun Chen, Xitai Sun, Yudong Qiu, Yitao Ding. Expression and significance of caveolin‑1 in hepatitis B virus‑associated hepatocellular carcinomaExperimental and Therapeutic Medicine 2017;  doi: 10.3892/etm.2017.5038
73
Hala Mosaad, Emad A. Emam, Emad F. Hamed, Ezzat A. El Demerdash, Samia Hussein. Vitamin D receptor gene polymorphism and hepatocellular carcinoma in chronic hepatitis C patientsEgyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00063-7
74
Shan Huang, Da Zhou, Yu‐Xuan Li, Zhi‐Yong Ming, Ke‐Zhi Li, Guo‐Bin Wu, Chuang Chen, Yin‐Nong Zhao. Retracted: In vivo and in vitro effects of microRNA‐221 on hepatocellular carcinoma development and progression through the JAK–STAT3 signaling pathway by targeting SOCS3Journal of Cellular Physiology 2019; 234(4): 3500 doi: 10.1002/jcp.26863
75
Harpreet Kaur, Sherry Bhalla, Gajendra P. S. Raghava, Ernest K. Amankwah. Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profilesPLOS ONE 2019; 14(9): e0221476 doi: 10.1371/journal.pone.0221476
76
Elissaios A. Kontis. Anesthesia for Hepatico-Pancreatic-Biliary Surgery and Transplantation2021; : 303 doi: 10.1007/978-3-030-51331-3_18
77
Xiao-Xiao Ding, Qing-Ge Zhu, Shi-Ming Zhang, Lei Guan, Ting Li, Lei Zhang, Shi-Yang Wang, Wan-Li Ren, Xue-Mei Chen, Jing Zhao, Song Lin, Zhi-Zhen Liu, Yan-Xia Bai, Bing He, Hu-Qin Zhang. Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapyOncotarget 2017; 8(33): 55715 doi: 10.18632/oncotarget.18382
78
Yun Zeng, Zhengjie Shen, Wenzhe Gu, Mianhua Wu. Inhibition of hepatocellular carcinoma tumorigenesis by curcumin may be associated with CDKN1A and CTGFGene 2018; 651: 183 doi: 10.1016/j.gene.2018.01.083
79
Samy Azer. MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?Journal of Clinical Medicine 2018; 7(4): 64 doi: 10.3390/jcm7040064
80
Di-yang Xie, Hong-kai Fan, Zheng-gang Ren, Jia Fan, Qiang Gao. Identifying Clonal Origin of Multifocal Hepatocellular Carcinoma and Its Clinical ImplicationsClinical and Translational Gastroenterology 2019; 10(2): e00006 doi: 10.14309/ctg.0000000000000006
81
Elisa Holstein, Mathias Binder, Wolfgang Mikulits. Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for TheranosticsInternational Journal of Molecular Sciences 2018; 19(12): 4111 doi: 10.3390/ijms19124111
82
Idy C.‐Y. Leung, Charing C.‐N. Chong, Tan T. Cheung, Philip C. Yeung, Kelvin K.‐C. Ng, Paul B.‐S. Lai, Stephen L. Chan, Anthony W.‐H. Chan, Patrick M.‐K. Tang, Siu T. Cheung. Genetic variation in ABCB5 associates with risk of hepatocellular carcinomaJournal of Cellular and Molecular Medicine 2020; 24(18): 10705 doi: 10.1111/jcmm.15691
83
Young-Joo Jin, Seyoun Byun, Seonggyun Han, John Chamberlin, Dongwook Kim, Min Jung Kim, Younghee Lee. Differential alternative splicing regulation among hepatocellular carcinoma with different risk factorsBMC Medical Genomics 2019; 12(S8) doi: 10.1186/s12920-019-0635-z
84
Simmone D'souza, Keith CK Lau, Carla S Coffin, Trushar R Patel. Molecular mechanisms of viral hepatitis induced hepatocellular carcinomaWorld Journal of Gastroenterology 2020; 26(38): 5759-5783 doi: 10.3748/wjg.v26.i38.5759
85
Han-Yu Jiang, Jie Chen, Chun-Chao Xia, Li-Kun Cao, Ting Duan, Bin Song. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosisWorld Journal of Gastroenterology 2018; 24(22): 2348-2362 doi: 10.3748/wjg.v24.i22.2348
86
Qiang Yu, Xia Yang, Weidong Duan, Chonghui Li, Ying Luo, Shichun Lu. miRNA-346 promotes proliferation, migration and invasion in liver cancerOncology Letters 2017; 14(3): 3255 doi: 10.3892/ol.2017.6561
87
Yingxue Lin, Yinhui Yao, Ying Wang, Lingdi Wang, Haipeng Cui, Tao Huang. PD-L1 and Immune Infiltration of m6A RNA Methylation Regulators and Its miRNA Regulators in Hepatocellular CarcinomaBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/5516100
88
Tao Wang, Zhiyuan Shao, Yifu Xiao, Xuchao Zhang, Yitian Chen, Binze Shi, Siyu Chen, Yuxian Wang, Jiajie Peng, Xuequn Shang. Predicting Hepatoma-Related Genes Based on Representation Learning of PPI network and Gene Ontology Annotations2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2021; : 1892 doi: 10.1109/BIBM52615.2021.9669479
89
Keisaku Sato, Fanyin Meng, Heather Francis, Nan Wu, Lixian Chen, Lindsey Kennedy, Tianhao Zhou, Antonio Franchitto, Paolo Onori, Eugenio Gaudio, Shannon Glaser, Gianfranco Alpini. Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapiesJournal of Pineal Research 2020; 68(3) doi: 10.1111/jpi.12639
90
Rodrigo Carlessi, Julia Köhn-Gaone, John K. Olynyk, Janina E. E. Tirnitz-Parker. Hepatocellular Carcinoma2019; : 69 doi: 10.15586/hepatocellularcarcinoma.2019.ch4
91
Yoshihiro Shioi, Mitsumasa Osakabe, Naoki Yanagawa, Hiroyuki Nitta, Akira Sasaki, Tamotsu Sugai. Analysis of somatic copy number alterations in biliary tract carcinoma using a single nucleotide polymorphism arrayFuture Science OA 2022; 8(1) doi: 10.2144/fsoa-2021-0057
92
Ye-Bin Lu, Qin Jiang, Man-Yi Yang, Ji-Xiang Zhou, Qi Zhang. Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axisOncotarget 2017; 8(51): 88804 doi: 10.18632/oncotarget.21321
93
Kyoko Oura, Asahiro Morishita, Joji Tani, Tsutomu Masaki. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2022; : 1279 doi: 10.2147/JHC.S392051
94
Lin Li, Yun-Feng Zhou, Yan-Lin Li, Li-Li Wang, Hiderori Arai, Yang Xu. <i>In vitro</i> and <i>in vivo</i> antioxidative and hepatoprotective activity of aqueous extract of Cortex DictamniWorld Journal of Gastroenterology 2017; 23(16): 2912-2927 doi: 10.3748/wjg.v23.i16.2912
95
Yali Liu, Wuyi Liu, Jingbin Huang, Wenjing Lai, Faning Leng, Changpeng Hu, Qian Zhang, Min Zhou, Qin Tang, Fangfang Sheng, Guobing Li, Rong Zhang. Cu2-xSe nanoparticles enhance the anticancer activity of oxaliplatin by inhibiting autophagic degradationNanomedicine 2019; 14(10): 1307 doi: 10.2217/nnm-2018-0284
96
Cristina Enríquez-Cortina, Oscar Bello-Monroy, Patricia Rosales-Cruz, Verónica Souza, Roxana U. Miranda, Rafael Toledo-Pérez, Armando Luna-López, Arturo Simoni-Nieves, Rogelio Hernández-Pando, María Concepción Gutiérrez-Ruiz, Diego F. Calvisi, Jens U. Marquardt, Leticia Bucio, Luis Enrique Gomez-Quiroz. Cholesterol overload in the liver aggravates oxidative stress-mediated DNA damage and accelerates hepatocarcinogenesisOncotarget 2017; 8(61): 104136 doi: 10.18632/oncotarget.22024
97
Yang Ge, Pengfei Gu, Wenbo Wang, Liyuan Cao, Lulu Zhang, Jingquan Li, Wei Mu, Hui Wang, Wei-Ping Jia. Benzo[a]pyrene stimulates miR-650 expression to promote the pathogenesis of fatty liver disease and hepatocellular carcinoma via SOCS3/JAK/STAT3 cascadesJournal of Molecular Cell Biology 2021;  doi: 10.1093/jmcb/mjab052